Skip to main content
Premium Trial:

Request an Annual Quote

Nasdaq Grants Accelrys Filing Extension for Quarterly Report

NEW YORK, Apr 17 (GenomeWeb News) - The Nasdaq exchange has granted Accelrys an extension to file its quarterly report for the period ended Dec. 31, 2005, the company said today.


The filing has been delayed because Accelrys is restating its quarterly financial statements from Jan. 1, 2000, to Sept. 30, 2005.


In Febraray, Nasdaq issued Accelrys a noncompliance notice because it had not yet filed its financial statements for its third fiscal quarter.


Today, Nasdaq extended the filing date to May 31. Accelrys stated that it expects to complete its quarterly report as well as its restated historical financial statements by that time.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.